International Association of Sickle Cell Nurses And Professional Associates
A Closer Look
meet some of our great nurses
Lori Vick,
President
Lori L. Vick is a registered nurse, educator, and researcher. She is a Clinical Associate Professor at the University of South Carolina, College of Nursing. Dr. Vick received a Bachelor of Science in Nursing/Biology from Iowa Wesleyan College in 1992, a Master of Arts in Teaching from Western Illinois University in 2005, and a Doctor of Philosophy in Nursing from the Medical University of South Carolina in 2016.
Dr. Vick’s nursing career has included academia, mental health, medical-surgical, oncology, intensive care, and research concerning persons with sickle cell disease. Her research comprisescollaborations to improve adherence to treatment and health management, pain and symptom management, pain and pharmacogenomics, healthcare disparities, and the relationship between pain and psychosocial disorders.
Coretta Jenerette, PhD, RN, AOCN, CNE, FAAN, is a Professor and the Associate Dean for Diversity, Equity, & Inclusivity in the College of Nursing at the University of South Carolina. In addition to being a certified nurse educator, Coretta's program of research is aimed at enhancing self-care and family management for individuals with sickle cell disease. She has been a member of IASCNAPA for more than 10 years.
Coretta Jenerette,
Treasurer
Janice Rambow Beatty, BSN is the sickle cell/thalassemia nurse specialist at the Ann and Robert H Lurie Children’s Hospital of Chicago. She has been in this position at Lurie Children’s (formerly Children’s Memorial Hospital) for 25 years working with the sickle cell and thalassemia patients and their families in all aspects of their disease processes. Janice is sickle cell/thalassemia researcher, educator, and speaker.
Janice Rambow Beatty,
Chairman of the Board
Dr. Dora Clayton-Jones, PhD, RN, CPNP-PC is an assistant professor at Marquette University in the College of Nursing and adjunct faculty member at the Medical College of Wisconsin. She completed her PhD and MS degrees in nursing at Marquette University. As a board-certified pediatric nurse practitioner, Dr. Clayton-Jones has expertise in school-based health and pediatric acute and chronic illnesses. Her research interests include self-management of chronic conditions during adolescence and early adulthood, spirituality and health, health equity, transition to adult health care, and qualitative research methods. Dr. Clayton-Jones is passionate about advocating for individuals living with sickle cell disease.
Dora Clayton-Jones,
Board Member
Cheryl Brewer,
Board Member
Dr. Cheryl Brewer is the Associate Vice President of Nursing for more than 100 ambulatory clinics of the Duke Private Diagnostic Clinic-Duke Health. She also serves as Clinical Associate Adjunct Faculty at Duke University School of Nursing.
Her sickle cell disease (SCD) research interests include factors that influence health-related quality of life, stigmatization, and self-care management. She is also an advocate for patients from vulnerable populations in pursuit of improved access to health care and resources.
Dr. Brewer is a member of several professional and community organizations including the International Association of Sickle Cell Nurses and Professional Associates. She is the recipient of the Duke Health Friends of Nursing Award for Excellence in Nursing Leadership, NC Honors Community Advocate Award, Triangle Business Journal Health Care Heroes Award, and NC Central University Distinguished Nursing Alumnus award, among others. She has also co-authored several publications related to SCD in peer-reviewed journals and delivers professional presentations at regional, national, and international conferences on the topics of SCD and professional nursing practice.
Pat Corley is a former sickle cell nurse at the University of Southern California. She worked with sickle cell patients as a nurse for nearly 40 years before retirement. Even after retirement, she is dedicated to educating health professionals, medical school students, and the public about the grave misconceptions about the devastating disease, as well as empowering patients to live their healthiest lives. She was honored at the 44th annual convention of the Sickle Cell Disease Association of America for her contribution of education, care, expertise, dedication, and commitment to the sickle cell community.
Pat Corley,
Board Member
Yvonne M. Carroll, RN, JD is the Director of Patient Services in the Department of Hematology at St. Jude Children’s Research Hospital (SJCRH). Yvonne graduated with a Bachelors of Nursing Degree from the University of Tennessee with honors and a Law degree from the University of Cincinnati. She joined SJCRH in 1999 in the Department of Hematology. Yvonne has been an advocate for the sickle cell community for more than 20 years. She serves as a member of the Governor’s Genetic Advisory Committee for Newborn Screening, and is the former President of the International Association of Sickle Cell Nurses and Professional Associates (IASCNAPA). She is project manager for multiple sickle cell grants and has published several peer reviewed articles . She is a military veteran and served as a Judge Advocate General (JAG) in the US Navy. She is passionate about her commitment to sickle cell disease and continues to develop and participate in projects to further research and improve care for people with the disease.
Yvonne M. Carroll,
Board Member
Dr. Cheedy Jaja,
Board Member
Dr. Cheedy Jaja is an Associate Professor in the College of Nursing at the University of South Carolina. His studies are in (SCD) pharmacogenetics and implementation science. Currently, he is pursuing two related SCD research initiatives. His principal partners in SCD Project are Jericho Road Community Health Center (New York); Augusta University, Georgia); The Sierra Leone Sickle Cell Society (England); and the Sickle Cell Carers Awareness Network (Sierra Leone).
The SCD project will establish a patient cohorts in Sierra Leone and will develop research initiatives to investigate the natural history of SCD in the patient cohorts. As an early-stage research scientist, Cheedy’s current research program also explores the role of drug metabolizing enzymes and transporter to identify at-risk SCD patients for analgesic drugs failure. His long-term research goal is to combine elements of pharmacogenetics, proteomic, and metabolomics for integrative “personalomics” profiling of SCD patients for individualized pain management and implementation research. He received a Fulbright Scholarship to help support his work in Sierra Leone.